Shufei Zeng

618 total citations
32 papers, 441 citations indexed

About

Shufei Zeng is a scholar working on Molecular Biology, Nephrology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Shufei Zeng has authored 32 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Nephrology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Shufei Zeng's work include Parathyroid Disorders and Treatments (7 papers), Sleep and related disorders (4 papers) and Genetic Syndromes and Imprinting (3 papers). Shufei Zeng is often cited by papers focused on Parathyroid Disorders and Treatments (7 papers), Sleep and related disorders (4 papers) and Genetic Syndromes and Imprinting (3 papers). Shufei Zeng collaborates with scholars based in China, Germany and Egypt. Shufei Zeng's co-authors include Berthold Hocher, Chang Chu, Ahmed A. Hasan, Michael Föller, Martina Feger, Florian Läng, Lars‐Oliver Klotz, Abul Fajol, Bernhard K. Krämer and Yong-Ping Lu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The FASEB Journal.

In The Last Decade

Shufei Zeng

31 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shufei Zeng China 13 156 145 69 67 65 32 441
Jovana Kaludjerovic Canada 14 150 1.0× 134 0.9× 173 2.5× 48 0.7× 127 2.0× 23 559
Niina Siitonen Finland 11 60 0.4× 121 0.8× 33 0.5× 82 1.2× 70 1.1× 13 631
Victoria Stokes United Kingdom 11 61 0.4× 57 0.4× 25 0.4× 143 2.1× 30 0.5× 21 358
Hsien‐Hsien Lei United States 5 93 0.6× 148 1.0× 116 1.7× 71 1.1× 133 2.0× 6 417
Raquel Yahyaoui Spain 11 118 0.8× 125 0.9× 65 0.9× 50 0.7× 50 0.8× 37 447
Małgorzata Marchelek‐Myśliwiec Poland 14 119 0.8× 217 1.5× 38 0.6× 17 0.3× 72 1.1× 47 474
Hongyang Jiang China 13 32 0.2× 129 0.9× 19 0.3× 56 0.8× 29 0.4× 33 545
Rebecca D. Murray United States 7 68 0.4× 79 0.5× 134 1.9× 40 0.6× 39 0.6× 9 325
Krithika Ramachandran United States 11 66 0.4× 243 1.7× 33 0.5× 31 0.5× 17 0.3× 22 500
Lidia Hyla‐Klekot Poland 10 62 0.4× 62 0.4× 46 0.7× 27 0.4× 31 0.5× 40 286

Countries citing papers authored by Shufei Zeng

Since Specialization
Citations

This map shows the geographic impact of Shufei Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shufei Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shufei Zeng more than expected).

Fields of papers citing papers by Shufei Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shufei Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shufei Zeng. The network helps show where Shufei Zeng may publish in the future.

Co-authorship network of co-authors of Shufei Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Shufei Zeng. A scholar is included among the top collaborators of Shufei Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shufei Zeng. Shufei Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Du, Shunda, Yuanhui Li, Shuai Liu, et al.. (2025). Association between post-COVID-19 sleep disturbance and neurocognitive function: a comparative study based on propensity score matching. Journal of Zhejiang University SCIENCE B. 26(2). 172–184. 1 indexed citations
2.
Zeng, Shufei, et al.. (2025). Anxiety, depressive and insomnia symptoms among patients with depression: a network perspective. BMC Psychology. 13(1). 496–496. 1 indexed citations
3.
Zeng, Shufei, Weimin Li, Yan Xu, et al.. (2024). Exploring sleep characteristics in Chinese patients with narcolepsy: insights from the nocturnal sleep onset rapid eye movement period (nSOREMP). Journal of Clinical Sleep Medicine. 20(8). 1349–1355. 1 indexed citations
4.
Chen, Xin, Shufei Zeng, Denis Delić, et al.. (2024). Comparison of sGC activator and sGC stimulator in 5/6 nephrectomized rats on high-salt-diet. Frontiers in Pharmacology. 15. 1480186–1480186. 2 indexed citations
5.
Zhang, Chenxi, et al.. (2024). Association between eicosapentaenoic acid consumption and the risk of depressive symptoms in US adults: Analyses from NHANES 2005–2018. Journal of Affective Disorders. 354. 62–67. 5 indexed citations
6.
7.
Zeng, Shufei, Yide Yang, Shuping Li, et al.. (2023). 25(OH)D-but not 1,25(OH)2D–Is an independent risk factor predicting graft loss in stable kidney transplant recipients. Frontiers in Medicine. 10. 1141646–1141646. 1 indexed citations
8.
Xiong, Yingquan, Denis Delić, Shufei Zeng, et al.. (2022). Regulation of SARS CoV-2 host factors in the kidney and heart in rats with 5/6 nephrectomy—effects of salt, ARB, DPP4 inhibitor and SGLT2 blocker. BMC Nephrology. 23(1). 117–117. 4 indexed citations
9.
Zeng, Shufei, Denis Delić, Chang Chu, et al.. (2021). Antifibrotic effects of low dose SGLT2 Inhibition with empagliflozin in comparison to Ang II receptor blockade with telmisartan in 5/6 nephrectomised rats on high salt diet. Biomedicine & Pharmacotherapy. 146. 112606–112606. 26 indexed citations
10.
Zeng, Shufei, Chang Chu, Cornelia Doebis, Hans‐Dieter Volk, & Berthold Hocher. (2021). Reference values for free 25-hydroxy-vitamin D based on established total 25-hydroxy-vitamin D reference values. The Journal of Steroid Biochemistry and Molecular Biology. 210. 105877–105877. 21 indexed citations
11.
Chu, Chang, Saban Elitok, Shufei Zeng, et al.. (2021). C-terminal and intact FGF23 in kidney transplant recipients and their associations with overall graft survival. BMC Nephrology. 22(1). 125–125. 19 indexed citations
12.
Chu, Chang, Ahmed A. Hasan, Mohamed M. S. Gaballa, et al.. (2020). Endostatin Is an Independent Risk Factor of Graft Loss after Kidney Transplant. American Journal of Nephrology. 51(5). 373–380. 3 indexed citations
13.
Zeng, Shufei, Uwe Querfeld, Martina Feger, et al.. (2020). Relationship between GFR, intact PTH, oxidized PTH, non‐oxidized PTH as well as FGF23 in patients with CKD. The FASEB Journal. 34(11). 15269–15281. 16 indexed citations
14.
Zeng, Shufei, Torsten Slowinski, Wolfgang Pommer, et al.. (2020). Sclerostin is an independent risk factor for all-cause mortality in kidney transplant recipients. Clinical and Experimental Nephrology. 24(12). 1177–1183. 7 indexed citations
15.
Lu, Yong-Ping, Shufei Zeng, Chang Chu, et al.. (2020). Non-oxidized PTH (n-oxPTH) is associated with graft loss in kidney transplant recipients. Clinica Chimica Acta. 508. 92–97. 6 indexed citations
16.
Hasan, Ahmed A., Karoline von Websky, Christoph Reichetzeder, et al.. (2019). Mechanisms of GLP-1 receptor–independent renoprotective effects of the dipeptidyl peptidase type 4 inhibitor linagliptin in GLP-1 receptor knockout mice with 5/6 nephrectomy. Kidney International. 95(6). 1373–1388. 31 indexed citations
17.
Feger, Martina, Abul Fajol, Lars‐Oliver Klotz, et al.. (2018). Insulin suppresses the production of fibroblast growth factor 23 (FGF23). Proceedings of the National Academy of Sciences. 115(22). 5804–5809. 100 indexed citations
18.
Luo, Ting, Xiaoyi Chen, Shufei Zeng, et al.. (2018). Bioinformatic identification of key genes and analysis of prognostic values in clear cell renal cell carcinoma. Oncology Letters. 16(2). 1747–1757. 20 indexed citations
19.
Wang, Guang, Peizhi Li, Shiyao Zhang, et al.. (2018). Lipopolysaccharides (LPS) Induced Angiogenesis During Chicken Embryogenesis is Abolished by Combined ETA/ETB Receptor Blockade. Cellular Physiology and Biochemistry. 48(5). 2084–2090. 3 indexed citations
20.
Zeng, Shufei, et al.. (2016). A Case Report of Acute Arterial Embolization of Right Lower Extremity As the Initial Presentation of Nephrotic Syndrome with Minimal Changes. Chinese Medical Sciences Journal. 31(4). 261–263. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jovana Kaludjerovic Breakdown of academic impact, for papers by Niina Siitonen Breakdown of academic impact, for papers by Victoria Stokes Breakdown of academic impact, for papers by Hsien‐Hsien Lei Breakdown of academic impact, for papers by Raquel Yahyaoui Breakdown of academic impact, for papers by Małgorzata Marchelek‐Myśliwiec Breakdown of academic impact, for papers by Hongyang Jiang Breakdown of academic impact, for papers by Rebecca D. Murray Breakdown of academic impact, for papers by Krithika Ramachandran Breakdown of academic impact, for papers by Lidia Hyla‐Klekot
Rankless by CCL
2026